Seneca Therapeutics

Overview

WE BELIEVE A CURE FOR CANCER IS WITHIN OUR LIFETIME AND WE ARE WORKING WITH URGENCY TO SEE THIS PROMISING POSSIBILITY BECOME A REALITY. Learn More.

Funding and backers

Total raised
$9.8M
5 rounds on record
Latest round
$1.6M
Venture round · Dec 2024 · 22 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
22 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 16, 2024 Raised a round Venture round $1.6M · SEC Form D Mar 12, 2021 Raised a round Venture round $7.7M · SEC Form D Jun 12, 2020 Raised a round Venture round $501k · SEC Form D Nov 14, 2019 Took on debt financing $820k · SEC Form D May 15, 2019 Took on debt financing $380k · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Dec 2024 $1.6M — SEC Form D
Venture round Mar 2021 $7.7M — SEC Form D
Venture round Jun 2020 $501k — SEC Form D
Debt Financing Nov 2019 $820k — SEC Form D
Debt Financing May 2019 $380k — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Seneca Therapeutics, Inc. SEC Form D
Founders and leadersfrom filings, registers and the company's site
Paul HallenbeckExecutive Officer, DirectorSEC Form D
James HusseyExecutive Officer, DirectorSEC Form D
Cuong DoExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Redalpine
backs Genialis
UTEC
backs PURMX Therapeutics
Illumina Ventures
backs Arima Genomics
Keio Innovation Initiative
backs PURMX Therapeutics
VCET
backs Cannatrol
Similar startupsby what they do, their industry and backers
SpringWorksTxVenture round $125M · 7 yr ago · Founded 2019 · 201-500 employees · 7 roles
We relentlessly pursue every possibility to create new cancer breakthroughs and power our approach with people who think hard, care hard…
PURMX TherapeuticsFounded 2021
Promising and Ultimate RNA Medicine. Aiming innovative nucleic acid drugs that cure patients.
Arima GenomicsSeries B · 4 yr ago · 51-200 employees
0 Built to find what cancer is hiding. What we believe No patient should miss a treatment opportunity because the right biomarker could not…
DopavisionVenture round $13M · 5 yr ago · Founded 2017
At Dopavision, we believe everyone deserves to see the world clearly through healthy eyes. Learn about our mission to develop an innovative…
GenialisVenture round $11.4M · 3 yr ago
Genialis is a precision oncology company helping the most promising molecules become life-saving medicines.
Cannatrol51-200 employees
Learn how to dry and cure cannabis the right way. Cannatrol.

Financials

Total raised
$11M
Latest round
Venture - Series Unknown
Funding rounds
5
Funding rounds
Round Announced Amount
Venture - Series Unknown 2024 $1.6M Details
Venture - Series Unknown 2021 $7.7M Details
Venture - Series Unknown 2020 $501k Details
Debt Financing 2019 $820k Details
Debt Financing 2019 $380k Details

People

Paul Hallenbeck
Executive Officer, Director
SEC Form D
James Hussey
Executive Officer, Director
SEC Form D
Cuong Do
Executive Officer, Director
SEC Form D
Mark Kerschner
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Blue Bell United States
HQ
50-200 est. staff